Fatty acid–binding proteins as emerging immunometabolic regulators and therapeutic targets in multiple sclerosis and neurodegeneration: Promise, mechanistic gaps, and translational hurdles

ASPET Discovery · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles